Jessica Richman is a co-founder of uBiome, a citizen science project that offers microbiome sequencing to the public, allowing you to submit samples, learn about your microbiome, and participate anonymously in crowdsourced research to help you solve some of the most important health questions of our time. She'll cover the latest scientific research on how our microbes can cause obesity, anxiety, heart disease, cavities, and sinusitis, or can contribute to adult, juvenile, and neonatal health. Jessica will also discuss why the microbiome offers the best chance for real personalized medicine in the near term and how you can get involved.
New: a Google+ ‘hangout’ will let you view the entire event LIVE on the day right here: https://plus.google.com/u/0/events/c9kj7m06a1d8tt8nf9ln22ecc18.
There are 100 trillion cells in each of our bodies, but only 10 trillion are human!
Who are the 90 percent? What are they doing there? And how do they affect our health?
We'll cover the latest scientific research on how our microbes can cause obesity, anxiety, heart disease, cavities, and sinusitis, or can contribute to adult, juvenile, and neonatal health.
We'll also discuss why the microbiome offers the best chance for real personalized medicine in the near term and how you can get involved.
Check out the citizen science uBiome sequencing project here: http://igg.me/p/276141.
Jessica Richman is a co-founder of uBiome, (www.indiegogo.com/ubiome), a citizen science project that offers microbiome sequencing to the public, allowing you to submit samples, learn about your microbiome, and participate anonymously in crowdsourced research to help you solve some of the most important health questions of our time.
Jessica Richman started and sold her first company after high school. Returning to formal education, she attended Stanford University, where she earned degrees in Economics and Science, Technology & Society (interdisciplinary engineering, emphasis in computer science). Along the way, she worked for Google, McKinsey, Lehman Brothers, the Grameen Bank, and top-tier Silicon Valley venture firms as well as other entrepreneurial projects and adventures. Her work has been published in The New York Times and other national publications.
Jessica arrived at Oxford University as a Clarendon Scholar and completed an MSc at the Oxford Internet Institute. Currently a Green Templeton DPhil Scholar, her academic interests include network analytics, innovation, and collective intelligence.
The Bible was the first scientific textbook. The double helix and the mushroom cloud have joined the Cross, the Crescent and the Star of David as global icons. Like the ancient scribes, the people who invented those two images seldom ask new questions, but — unlike them — they do sometimes come up with new answers. The topics studied by today's physicists, astronomers and biologists have obsessed mankind since long before their subjects began. Although science does rather better at providing answers than do the Testaments, we sometimes find it as hard to decide what to do with the information as did the prophets of old.
Steve Jones will discuss in particular the overlap between new work on genetic predisposition with the ancient idea of inborn human frailty, of original sin, in fields as distinct as sport, obesity and crime.
This is a co-talk with Oxford BioSoc.
Head of the department of Genetics, Environment and Evolution at UCL, Professor Jones is a television presenter and prize-winning author. In 1996 his writing won him the Royal Society's Michael Faraday Prize. In this week's talk (co-hosted by the Oxford University Biological Society), Professor Jones will discuss the overlap between new work on genetic predisposition with the ancient idea of inborn human frailty, of original sin, in fields as distinct as sport, obesity and crime.
The talk will be on public perceptions of neuroscience, why they're often wrong, and why neuroscientists should care — and change.
- From Jennifer Rohn at Mind the Gap:
- From the Fixing Psychology blog:‘For those who don't know, Neuroskeptic is one of the more popular science bloggers in the world. He is a research-active British neuroscientist, who has been highlighting important findings, and criticizing public (and professional) misunderstandings of those findings for several years. He does this anonymously, and even the people in his home department do not know his identity. His blog-icon is what initially appears to be a stupid picture of a disembodied brain with two eye balls; though that is closer to what he looks like than you might think.’
- Neuro_Skeptic on Twitter
The talk will be on the physics of such objects and include live demonstrations.
Spinning things are strange. Why does a spinning top stand up? Why doesn't a rolling wheel fall over? Why is top-spin so effective in tennis? How does a falling cat always manage to land on its feet? How can the Hubble Space Telescope turn around in space? What do ice-skaters do to spin so fast? We'll look closely at the common threads that link all spinning things, and that means we'll have to talk about gyroscopes. Don't worry, there won't be any maths. Everything will be demonstrated live with lots of toys and videos. And we'll even throw a few indoor boomerangs — hoping not to break any windows!
Dr Hugh Hunt is Senior Lecturer at Cambridge University, Fellow of Trinity College. He often appears in different TV and radio programmes including National Geographic, Richard Hammond's “Engineering Connections”, Dambusters and Colditz — doing it all again and Hamish and Andy's European Gap Year — Attempt to pedal an Aquabike across the Strait of Gibraltar (full list at http://www2.eng.cam.ac.uk/~hemh/tv.htm).
From deadly nightshade to eye surgery and truth drugs; from poison gas to pesticides and cancer therapy; from explosives to treatments for heart disease; from natural toxins to new starting points for drug discovery. The unexpected relationship between chemical weapons and medicines will be explored, interspersed with curious parallels drawn from the speaker's 20 years of being a chemist.
This event is free and open to everyone. Please arrive early (by 18:30) to be seated.
Gary Taubes is an American science writer. He is the author of Nobel Dreams (1987), Bad Science: The Short Life and Weird Times of Cold Fusion (1993), and Good Calories, Bad Calories (2007), which is titled The Diet Delusion in the UK. He has won the Science in Society Award of the National Association of Science Writers three times and was awarded an MIT Knight Science Journalism Fellowship for 1996–97.
Born in Rochester, New York, Taubes studied applied physics at Harvard and aerospace engineering at Stanford (MS, 1978). After receiving a master's degree in journalism at Columbia University in 1981, Taubes joined Discover magazine as a staff reporter in 1982. Since then he has written numerous articles for Discover, Science and other magazines. Originally focusing on physics issues, his interests have more recently turned to medicine and nutrition.
Prof. Philip James trained in physiology, biochemistry and medicine in University College London, UK and had post-graduate training in the UK, in Jamaica with the Medical Research Council and in the US with the Wellcome Trust. He was secretary of the first UK MRC and Dept of Health report on obesity research in 1976, wrote the obesity report for the Royal College of Physicians in 1983, established the MRC Dunn Clinical Nutrition Centre in Cambridge building both indirect and direct calorimeters to study energy balance in obesity, chaired the UK's first public health approach to obesity and later on childhood obesity, chaired the first SIGN guidelines on obesity management and established and ran the International Obesity Task Force for a decade. He organised the first WHO global analysis of obesity, developed the organisation of the current IASO of which he is President and undertook the first global burden analyses for WHO on obesity 12 years ago. He was the Director of the Rowett Research Institute in Aberdeen for 17 years and is now chief advisor on nutritional aspects of public health initiatives for the regional offices of WHO covering 75 countries.
Prof. Sir Richard Peto is Professor of Medical Statistics & Epidemiology at the University of Oxford, and director of the Clinical Trial Service Unit. His work has included studies of the causes of cancer, particularly the effects of smoking, and the establishment of large scale randomized trials. He has been instrumental in introducing combined ‘meta-analyses’ of results from related trials that achieve uniquely reliable assessment of treatment effects. He was elected a Fellow of the Royal Society (for the introduction of meta-analyses) in 1989, and was knighted (for services to epidemiology and to cancer prevention) in 1999.
This event is partially subsidized by Bioline.
The talk will focus on Prof Miesenböck's work in optogenetics.
In the quest to map the brain, many scientists have attempted the incredibly daunting task of recording the activity of each neuron. Gero Miesenböck works backward — manipulating specific neurons to figure out exactly what they do, through a series of stunning experiments that reengineer the way fruit flies perceive light.
Using light and a little genetic engineering — optogenetics — Gero Miesenboeck has developed a way to control how living nerve cells work, and advanced understanding of how the brain controls behaviour.
Gero Miesenböck studied medicine at the University of Innsbruck in his native Austria and did postdoctoral research at Memorial Sloan-Kettering Cancer Centre in New York. He was on the faculty of Memorial Sloan-Kettering Cancer Centre and Yale University before coming to Oxford in 2007. Gero is the founding director of the CNCB.
In chemical science as well as in most branches of natural philosophy, expert practitioners of their subject — judging by past experience — are often no better than members of the general public in foreseeing the scientific and technological future. The veracity of this statement will be illustrated (in terms that will also be intelligible to non-experts), and the reasons why this is so will be elaborated by reference to specific discoveries, advances and developments in chemistry, physics, medicine, molecular biology and astronomy.